Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_assertion type Assertion NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_head.
- NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_assertion description "[The combined treatment with anti-miR-155 and losartan has a synergistic antiproliferative effect and an improved understanding is required to clarify whether miR-155 and AGTR1 can be used as a novel therapeutic target in endometrial cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_provenance.
- NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_assertion evidence source_evidence_literature NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_provenance.
- NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_assertion SIO_000772 22525818 NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_provenance.
- NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_assertion wasDerivedFrom befree-2016 NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_provenance.
- NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_assertion wasGeneratedBy ECO_0000203 NP976799.RAr8Z3j0Dw1odb-juDOEMOmaGkFJm5DBb7kC2r4lwXwHA130_provenance.